China Resources Boya Bio-Pharmaceutical Group Co., Ltd is a company located in Fuzhou, Jiangxi Province. It is the only designated blood product production unit in the province. The company specializes in the production of three main categories of products: albumin, immunoglobulin, and coagulation factors. It is one of the leading manufacturers of human blood albumin and intravenous human immunoglobulin in terms of product specifications. The company is also involved in the research and development of various other products, including coagulation factor VIII (AHG), prothrombin complex concentrate (PCC), human fibrin glue (FS), tetanus human immunoglobulin (HTIG), hand, foot, and mouth disease human immunoglobulin, and recombinant factor products. The company's products have been recognized by distributors and key cooperative hospitals for their excellent quality and have been awarded as new products or high-tech products in Jiangxi Province. On August 2, 2017, the company changed its name from "Jiangxi Boya Bio-Pharmaceutical Co., Ltd" to "Boya Bio-Pharmaceutical Group Co., Ltd." On March 22, 2022, the company changed its Chinese name from "Boya Bio-Pharmaceutical Group Co., Ltd" to "China Resources Boya Bio-Pharmaceutical Group Co., Ltd."
Headquarters
No. 333, Huiquan Road, High-tech Industrial Park, Fuzhou City, Jiangxi Province
Fuzhou; Jiangxi;
Postal Code: 344000
Contact Details: Purchase the China Resources Boya Bio-Pharmaceutical Group Co., Ltd (华润博雅生物制药集团股份有限公司) report to view the information.
Website: http://www.china-boya.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service